• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

河马通路中的可变剪接——对疾病的影响及潜在治疗靶点

Alternative Splicing in the Hippo Pathway-Implications for Disease and Potential Therapeutic Targets.

作者信息

Porazinski Sean, Ladomery Michael

机构信息

Faculty of Health and Applied Sciences, University of the West of England, Frenchay Campus, Bristol BS16 1QY, UK.

出版信息

Genes (Basel). 2018 Mar 13;9(3):161. doi: 10.3390/genes9030161.

DOI:10.3390/genes9030161
PMID:29534050
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5867882/
Abstract

Alternative splicing is a well-studied gene regulatory mechanism that produces biological diversity by allowing the production of multiple protein isoforms from a single gene. An involvement of alternative splicing in the key biological signalling Hippo pathway is emerging and offers new therapeutic avenues. This review discusses examples of alternative splicing in the Hippo pathway, how deregulation of these processes may contribute to disease and whether these processes offer new potential therapeutic targets.

摘要

可变剪接是一种经过充分研究的基因调控机制,它通过允许从单个基因产生多种蛋白质异构体来产生生物多样性。可变剪接在关键的生物信号通路——Hippo通路中的作用正在显现,并提供了新的治疗途径。本文综述了Hippo通路中可变剪接的实例,这些过程的失调如何导致疾病,以及这些过程是否提供了新的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a49/5867882/e21de0d87180/genes-09-00161-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a49/5867882/e21de0d87180/genes-09-00161-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a49/5867882/e21de0d87180/genes-09-00161-g001.jpg

相似文献

1
Alternative Splicing in the Hippo Pathway-Implications for Disease and Potential Therapeutic Targets.河马通路中的可变剪接——对疾病的影响及潜在治疗靶点
Genes (Basel). 2018 Mar 13;9(3):161. doi: 10.3390/genes9030161.
2
Alternative splicing within the Wnt signaling pathway: role in cancer development.Wnt信号通路中的可变剪接:在癌症发展中的作用
Cell Oncol (Dordr). 2016 Feb;39(1):1-13. doi: 10.1007/s13402-015-0266-0. Epub 2016 Jan 13.
3
Splicing in the immune system: potential targets for therapeutic intervention by antisense-mediated alternative splicing.免疫系统中的剪接:反义介导的可变剪接作为治疗干预的潜在靶点
Curr Opin Mol Ther. 2009 Apr;11(2):124-32.
4
Determining the impact of alternative splicing events on transcriptome dynamics.确定可变剪接事件对转录组动态变化的影响。
BMC Res Notes. 2008 Oct 24;1:94. doi: 10.1186/1756-0500-1-94.
5
Disease implication of hyper-Hippo signalling.高活性Hippo信号通路的疾病关联
Open Biol. 2016 Oct;6(10). doi: 10.1098/rsob.160119.
6
Wnt, RSPO and Hippo Signalling in the Intestine and Intestinal Stem Cells.肠道及肠道干细胞中的Wnt、RSPO和Hippo信号通路
Genes (Basel). 2018 Jan 8;9(1):20. doi: 10.3390/genes9010020.
7
Alternative transcription and alternative splicing in cancer.癌症中的可变转录和可变剪接。
Pharmacol Ther. 2012 Dec;136(3):283-94. doi: 10.1016/j.pharmthera.2012.08.005. Epub 2012 Aug 14.
8
Alternative splicing: an emerging topic in molecular and clinical oncology.可变剪接:分子与临床肿瘤学中的一个新兴话题。
Lancet Oncol. 2007 Apr;8(4):349-57. doi: 10.1016/S1470-2045(07)70104-3.
9
Alternative splicing: current perspectives.可变剪接:当前观点
Bioessays. 2008 Jan;30(1):38-47. doi: 10.1002/bies.20692.
10
Normal and aberrant splicing of LMNA.LMNA的正常和异常剪接
J Med Genet. 2014 Apr;51(4):215-23. doi: 10.1136/jmedgenet-2013-102119. Epub 2014 Jan 23.

引用本文的文献

1
Pharmacological inhibition of CLK2 activates YAP by promoting alternative splicing of AMOTL2.药物抑制 CLK2 通过促进 AMOTL2 的选择性剪接来激活 YAP。
Elife. 2023 Dec 21;12:RP88508. doi: 10.7554/eLife.88508.
2
Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP.恶性胸膜间皮瘤的分子改变:通过靶向 YAP 实现有效治疗的希望。
Target Oncol. 2022 Jul;17(4):407-431. doi: 10.1007/s11523-022-00900-2. Epub 2022 Jul 30.
3
Circular RNAs modulate Hippo-YAP signaling: functional mechanisms in cancer.

本文引用的文献

1
Developmental YAPdeltaC determines adult pathology in a model of spinocerebellar ataxia type 1.发育性 YAPdeltaC 在脊髓小脑共济失调 1 型模型中决定成人病理学。
Nat Commun. 2017 Nov 30;8(1):1864. doi: 10.1038/s41467-017-01790-z.
2
YAP/TAZ-CDC42 signaling regulates vascular tip cell migration.YAP/TAZ-CDC42 信号通路调控血管尖端细胞迁移。
Proc Natl Acad Sci U S A. 2017 Oct 10;114(41):10918-10923. doi: 10.1073/pnas.1704030114. Epub 2017 Sep 25.
3
Mechanobiology of YAP and TAZ in physiology and disease.YAP和TAZ在生理与疾病中的力学生物学
环状 RNAs 调控 Hippo-YAP 信号通路:癌症中的功能机制。
Theranostics. 2022 May 16;12(9):4269-4287. doi: 10.7150/thno.71708. eCollection 2022.
4
Alternative Splicing-Based Differences Between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Genes, Immune Microenvironment, and Survival Prognosis.基于可变剪接的肝细胞癌与肝内胆管癌之间的差异:基因、免疫微环境和生存预后
Front Oncol. 2021 Oct 25;11:731993. doi: 10.3389/fonc.2021.731993. eCollection 2021.
5
Prognostic Value and Potential Role of Alternative mRNA Splicing Events in Cervical Cancer.可变mRNA剪接事件在宫颈癌中的预后价值及潜在作用
Front Genet. 2020 Jul 10;11:726. doi: 10.3389/fgene.2020.00726. eCollection 2020.
6
Survival-associated alternative splicing signatures in non-small cell lung cancer.非小细胞肺癌中与生存相关的可变剪接特征。
Aging (Albany NY). 2020 Apr 13;12(7):5878-5893. doi: 10.18632/aging.102983.
7
Systematic Analysis of Survival-Associated Alternative Splicing Signatures in Gastrointestinal Pan-Adenocarcinomas.系统分析胃肠道胰腺腺癌中与生存相关的可变剪接特征。
EBioMedicine. 2018 Aug;34:46-60. doi: 10.1016/j.ebiom.2018.07.040. Epub 2018 Aug 18.
Nat Rev Mol Cell Biol. 2017 Dec;18(12):758-770. doi: 10.1038/nrm.2017.87. Epub 2017 Sep 27.
4
Stable MOB1 interaction with Hippo/MST is not essential for development and tissue growth control.稳定的 MOB1 与 Hippo/MST 的相互作用对于发育和组织生长控制并非必需。
Nat Commun. 2017 Sep 25;8(1):695. doi: 10.1038/s41467-017-00795-y.
5
Fibulin-5 promotes airway smooth muscle cell proliferation and migration via modulating Hippo-YAP/TAZ pathway.纤连蛋白-5通过调节Hippo-YAP/TAZ信号通路促进气道平滑肌细胞增殖和迁移。
Biochem Biophys Res Commun. 2017 Nov 18;493(2):985-991. doi: 10.1016/j.bbrc.2017.09.105. Epub 2017 Sep 20.
6
Effect of cadmium on kitl pre-mRNA alternative splicing in murine ovarian granulosa cells and its associated regulation by miRNAs.镉对小鼠卵巢颗粒细胞 kitl 前体 mRNA 可变剪接的影响及其与 miRNA 的相关调控。
J Appl Toxicol. 2018 Feb;38(2):227-239. doi: 10.1002/jat.3516. Epub 2017 Sep 11.
7
The Functional Impact of Alternative Splicing in Cancer.可变剪接在癌症中的功能影响
Cell Rep. 2017 Aug 29;20(9):2215-2226. doi: 10.1016/j.celrep.2017.08.012.
8
Abnormalities in alternative splicing in diabetes: therapeutic targets.糖尿病中选择性剪接的异常:治疗靶点。
J Mol Endocrinol. 2017 Aug;59(2):R93-R107. doi: 10.1530/JME-17-0049.
9
Normal and altered pre-mRNA processing in the DMD gene.杜兴氏肌营养不良症(DMD)基因中正常和异常的前体信使核糖核酸(pre-mRNA)加工过程
Hum Genet. 2017 Sep;136(9):1155-1172. doi: 10.1007/s00439-017-1820-9. Epub 2017 Jun 9.
10
Development of an orally available inhibitor of CLK1 for skipping a mutated dystrophin exon in Duchenne muscular dystrophy.开发一种可口服的 CLK1 抑制剂,用于跳过杜氏肌营养不良症中的突变肌营养不良蛋白外显子。
Sci Rep. 2017 May 30;7:46126. doi: 10.1038/srep46126.